| scholarly article | Q13442814 |
| P50 | author | Douglas Cines | Q16204220 |
| Serge Yarovoi | Q124218059 | ||
| Khalil Bdeir | Q124218060 | ||
| Victoria Stepanova | Q125230015 | ||
| Michael S. Marks | Q38305771 | ||
| P2093 | author name string | Abd Al-Roof Higazi | |
| Yelena Parfyonova | |||
| Tatiana Lebedeva | |||
| Sergei Zaitsev | |||
| Inna Dumler | |||
| Alice Kuo | |||
| Vsevolod A Tkachuk | |||
| Sergei Tkachuk | |||
| P2860 | cites work | The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain. Characterization of interactions and contribution to chemotaxis | Q22253459 |
| Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis | Q24299135 | ||
| The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin | Q24300666 | ||
| Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin | Q24317515 | ||
| Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes | Q24532196 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility | Q28212178 | ||
| The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor | Q28216327 | ||
| The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis | Q28235072 | ||
| Pleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolin | Q28271787 | ||
| Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells | Q43551857 | ||
| Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction | Q44097437 | ||
| The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases | Q44354200 | ||
| The kringle stabilizes urokinase binding to the urokinase receptor | Q47735737 | ||
| Nucleolin interacts with several ribosomal proteins through its RGG domain. | Q47828267 | ||
| Protein phosphorylation sites regulate the function of the bipartite NLS of nucleolin | Q48953948 | ||
| Nuclear export of proteins: the role of nuclear retention. | Q49136533 | ||
| Nuclei from rat liver: isolation method that combines purity with high yield | Q49488035 | ||
| Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation. | Q51809541 | ||
| LDL receptor-related protein internalizes and degrades uPA-PAI-1 complexes and is essential for embryo implantation | Q52478181 | ||
| Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains. | Q53970125 | ||
| Enzymatic properties of single-chain and two-chain forms of a Lys158----Glu158 mutant of urokinase-type plasminogen activator | Q69914168 | ||
| Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice | Q71067669 | ||
| Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase | Q72098003 | ||
| Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells | Q73140073 | ||
| Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase | Q73589777 | ||
| Activation of p38 MAP-kinase and caldesmon phosphorylation are essential for urokinase-induced human smooth muscle cell migration | Q77873801 | ||
| Structure and function of the plasminogen/plasmin system | Q81668319 | ||
| Nucleolin: a multifunctional major nucleolar phosphoprotein | Q28295172 | ||
| Human DNA helicase IV is nucleolin, an RNA helicase modulated by phosphorylation | Q28295537 | ||
| Ecto-protein kinase substrate p120 revealed as the cell-surface-expressed nucleolar phosphoprotein Nopp140: a candidate protein for extracellular Ca2+-sensing | Q28365833 | ||
| Urokinase plasminogen activator in injured adventitia increases the number of myofibroblasts and augments early proliferation | Q28565046 | ||
| A 110-kD nuclear shuttling protein, nucleolin, binds to the neurite-promoting IKVAV site of laminin-1 | Q28574881 | ||
| Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo | Q29616612 | ||
| Major nucleolar proteins shuttle between nucleus and cytoplasm | Q29620425 | ||
| Regulation of dna replication after heat shock by replication protein a-nucleolin interactions | Q30673624 | ||
| Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin. | Q30828562 | ||
| Novel checkpoint response to genotoxic stress mediated by nucleolin-replication protein a complex formation | Q31150971 | ||
| In vitro selection of single-stranded DNA aptamers that bind human pro-urokinase | Q33209224 | ||
| FGF-1 and FGF-2 require the cytosolic chaperone Hsp90 for translocation into the cytosol and the cell nucleus | Q33234533 | ||
| Structure and functions of nucleolin. | Q33536089 | ||
| Molecular dissection of nucleolin's role in growth and cell proliferation: new insights | Q33764019 | ||
| Alpha-smooth muscle actin expression upregulates fibroblast contractile activity | Q33946717 | ||
| uPAR: a versatile signalling orchestrator | Q34162183 | ||
| Nuclear targeting by the growth factor midkine | Q34286252 | ||
| Tumor-associated urokinase-type plasminogen activator: biological and clinical significance | Q35777083 | ||
| Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels | Q36324866 | ||
| Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer | Q36371206 | ||
| Determination of the functional domains involved in nucleolar targeting of nucleolin | Q37376748 | ||
| Nucleolin is a matrix attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential | Q38300450 | ||
| Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo | Q38310818 | ||
| Anti-angiogenic activity of the recombinant kringle domain of urokinase and its specific entry into endothelial cells. | Q38358693 | ||
| The receptor for urokinase-plasminogen activator. | Q39505756 | ||
| Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy. | Q40165011 | ||
| Induction of p53 by urokinase in lung epithelial cells | Q40413239 | ||
| Translocation of FGF-1 and FGF-2 across vesicular membranes occurs during G1-phase by a common mechanism | Q40509934 | ||
| Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration | Q40695132 | ||
| Urokinase induces its own expression in Beas2B lung epithelial cells | Q40718884 | ||
| Identification of nucleolin as a new L-selectin ligand | Q40764932 | ||
| Nuclear localization of EGF receptor and its potential new role as a transcription factor | Q40782527 | ||
| A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid | Q40954235 | ||
| siRNA Selection Server: an automated siRNA oligonucleotide prediction server | Q41010535 | ||
| Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia | Q41548309 | ||
| A protein partially expressed on the surface of HepG2 cells that binds lipoproteins specifically is nucleolin | Q41717933 | ||
| Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression | Q42754658 | ||
| Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands | Q42807171 | ||
| Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against | Q42833221 | ||
| Plasmin-dependent elimination of the growth-factor-like domain in urokinase causes its rapid cellular uptake and degradation. | Q42999092 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen | Q107129060 |
| P304 | page(s) | 100-110 | |
| P577 | publication date | 2008-03-12 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Nuclear translocation of urokinase-type plasminogen activator | |
| P478 | volume | 112 |
| Q34385625 | Aggregated low-density lipoprotein induce impairment of the cytoskeleton dynamics through urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor in human vascular smooth muscle cell |
| Q39368829 | Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. |
| Q37566249 | Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. |
| Q41197179 | Copine-7 binds to the cell surface receptor, nucleolin, and regulates ciliogenesis and Dspp expression during odontoblast differentiation. |
| Q39028976 | Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy |
| Q33774606 | DNA damage-induced translocation of S100A11 into the nucleus regulates cell proliferation |
| Q35005500 | Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death |
| Q37529843 | Emerging drugs for the therapy of primary and post essential thrombocythemia, post polycythemia vera myelofibrosis |
| Q38367291 | Enhancing FTS (Salirasib) efficiency via combinatorial treatment |
| Q36053965 | Expression of Nucleolin Affects Microtubule Dynamics |
| Q36112952 | Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration. |
| Q37152354 | Human tissue factor pathway inhibitor-2 is internalized by cells and translocated to the nucleus by the importin system |
| Q38303924 | Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma. |
| Q37131462 | Multifunctional roles of urokinase plasminogen activator (uPA) in cancer stemness and chemoresistance of pancreatic cancer. |
| Q34656695 | Novel mechanism regulating endothelial permeability via T-cadherin-dependent VE-cadherin phosphorylation and clathrin-mediated endocytosis |
| Q34475097 | Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L |
| Q50739041 | Proteomic analysis reveals a proteolytic feedback loop in murine seminal fluid. |
| Q34606581 | Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator. |
| Q37372370 | Senescence, apoptosis, and stem cell biology: the rationale for an expanded view of intracrine action |
| Q33478425 | Structure-function analysis of nucleolin and ErbB receptors interactions |
| Q28472975 | Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin |
| Q33784401 | Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization |
| Q33614407 | Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice |
| Q33980633 | Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type |
| Q54077957 | The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells. |
| Q39232685 | The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis |
| Q37968531 | Transformation of a chronic myeloproliferative neoplasm to acute myelogenous leukemia: does anything work? |
| Q37098900 | Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression |
| Q35067747 | Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase |
| Q41973656 | Urokinase-type plasminogen activator inhibits efferocytosis of neutrophils |
Search more.